Ansgar Weltermann

Ansgar Weltermann

UNVERIFIED PROFILE

Are you Ansgar Weltermann?   Register this Author

Register author
Ansgar Weltermann

Ansgar Weltermann

Publications by authors named "Ansgar Weltermann"

Are you Ansgar Weltermann?   Register this Author

44Publications

845Reads

15Profile Views

Recommendations for ibrutinib treatment in patients with atrial fibrillation and/or elevated cardiovascular risk.

Wien Klin Wochenschr 2019 Aug 14. Epub 2019 Aug 14.

University Clinic of Internal Medicine V, Hematology and Oncology, Medical University of Innsbruck, Innsbruck, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00508-019-1534-1DOI Listing
August 2019

Karyotype plus NPM1 mutation status defines a group of elderly patients with AML (≥60 years) who benefit from intensive post-induction consolidation therapy.

Am J Hematol 2016 12 8;91(12):1239-1245. Epub 2016 Nov 8.

Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.24560DOI Listing
December 2016

Lapatinib-plus-pegylated liposomal doxorubicin in advanced HER2-positive breast cancer following trastuzumab: a phase II trial.

Anticancer Res 2015 Jan;35(1):517-21

3rd Medical Department with Haematology, Medical Oncology, Hemostaseology, Infectious Diseases, Rheumatology, Oncologic Centre, Salzburg Cancer Research Institute (SCRI) with the Laboratory of Immunological and Molecular Cancer Research (SCRI-LIMCR) and the Center for Clinical Cancer and Immunology Trials (SCRI-CCCIT), Paracelsus Medical University Salzburg, Salzburg, Austria

View Article

Download full-text PDF

Source
January 2015

A SAGE based approach to human glomerular endothelium: defining the transcriptome, finding a novel molecule and highlighting endothelial diversity.

BMC Genomics 2014 Aug 27;15:725. Epub 2014 Aug 27.

Department of Medicine III, Division of Nephrology and Dialysis, Medical University of Vienna, Waehringer Guertel 18 - 20, A-1090 Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2164-15-725DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4156628PMC
August 2014

Platelet endothelial cell adhesion molecule 1 deficiency misguides venous thrombus resolution.

Blood 2013 Nov 30;122(19):3376-84. Epub 2013 Sep 30.

Department of Internal Medicine I, Elisabethinen Hospital, Linz, Austria;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2013-04-499558DOI Listing
November 2013

Management of dabigatran-induced bleeding: expert statement.

Wien Klin Wochenschr 2013 Nov 12;125(21-22):721-9. Epub 2013 Nov 12.

Department of Anesthesia and Intensive Care, Medical University Innsbruck, Innsbruck, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00508-013-0430-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3838590PMC
November 2013

Tissue factor exposing microparticles in inflammatory bowel disease.

J Crohns Colitis 2013 Apr 15;7(3):222-9. Epub 2012 Jun 15.

Department of Internal Medicine III, Division of Gastroenterology and Hepatology; Medical University of Vienna, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.crohns.2012.05.016DOI Listing
April 2013

Low dose acetylsalicylic acid and shedding of microparticles in vivo in humans.

Eur J Clin Invest 2010 Jun 26;40(6):477-82. Epub 2010 Apr 26.

Department of Medicine I, Medical University of Vienna, Vienna, Austria.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/j.1365-2362.2010.02299.x
Publisher Site
http://dx.doi.org/10.1111/j.1365-2362.2010.02299.xDOI Listing
June 2010

Circulating tissue factor-exposing microparticles.

Thromb Res 2008 ;122 Suppl 1:S47-54

Department of Medicine I, Medical University of Vienna, Vienna, Austria.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00493848087001
Publisher Site
http://dx.doi.org/10.1016/S0049-3848(08)70019-7DOI Listing
November 2008

Genetic variation in heme oxygenase 1 (HMOX1) and the risk of recurrent venous thromboembolism.

J Vasc Surg 2008 Mar 16;47(3):566-70. Epub 2008 Jan 16.

Institute of Medical and Chemical Laboratory Diagnostics, Medical University of Vienna, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jvs.2007.09.060DOI Listing
March 2008

Chemotherapy-induced thrombosis: a role for microparticles and tissue factor?

Semin Thromb Hemost 2008 Mar;34(2):199-203

Department of Medicine I, Medical University of Vienna, Vienna, Austria.

View Article

Download full-text PDF

Source
https://www.thieme-connect.com/products/ejournals/pdf/10.105
Web Search
http://dx.doi.org/10.1055/s-2008-1079261DOI Listing
March 2008

[Adult autoimmune thrombocytopenia: diagnosis and treatment].

Wien Klin Wochenschr 2006 May;118(9-10):255-64

Abteilung Hämatologie/Hämostaseologie, Universitätsklinik für Innere Medizin I, Medizinische Universität Wien, Wien, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00508-006-0602-5DOI Listing
May 2006

Family history for venous thromboembolism and the risk for recurrence.

Am J Med 2006 Jan;119(1):50-3

Department of Internal Medicine I, Division of Angiology, Medical University of Vienna, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.amjmed.2005.04.043DOI Listing
January 2006

Symptomatic venous thromboembolism in acute leukemia. Incidence, risk factors, and impact on prognosis.

Thromb Res 2005 ;115(1-2):59-64

Division of Haematology and Haemostasis, Department of Internal Medicine I, Medical University of Vienna, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.thromres.2004.07.016DOI Listing
May 2005

Mortality in severe, non aggressively treated adult autoimmune thrombocytopenia.

Hematol J 2003 ;4(5):366-9

Department of Medicine I, Division of Hematology and Blood Coagulation, University of Vienna, Austria.

View Article

Download full-text PDF

Source
http://www.nature.com/doifinder/10.1038/sj.thj.6200299
Publisher Site
http://dx.doi.org/10.1038/sj.thj.6200299DOI Listing
June 2004

Effects of pretreatment with clopidogrel on platelet and coagulation activation in patients undergoing elective coronary stenting.

Thromb Res 2003 ;112(1-2):19-24

Department of Internal Medicine I, Division of Hematology and Hemostasis, Vienna University Hospital, Währinger Gürtel 18-20, A-1090 Vienna, Austria.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S004938480300549
Publisher Site
http://dx.doi.org/10.1016/j.thromres.2003.10.020DOI Listing
June 2004

The risk of recurrent venous thromboembolism in men and women.

N Engl J Med 2004 Jun;350(25):2558-63

Department of Internal Medicine I, Division of Hematology and Hemostasis, Ludwig Boltzmann-Institut fur Thromboseforschung, Vienna, Austria.

View Article

Download full-text PDF

Source
http://www.nejm.org/doi/abs/10.1056/NEJMoa032959
Publisher Site
http://dx.doi.org/10.1056/NEJMoa032959DOI Listing
June 2004

Thrombin-activatable fibrinolysis inhibitor and the risk for recurrent venous thromboembolism.

Blood 2004 May 22;103(10):3773-6. Epub 2004 Jan 22.

Department of Internal Medicine I, University of Vienna, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2003-10-3422DOI Listing
May 2004

Novel anticoagulants for the prevention and treatment of venous thromboembolism.

Wien Med Wochenschr 2003 ;153(19-20):426-33

Division of Hematology and Hemostaseology, Department of Internal Medicine I, University of Vienna, Währinger Gürtel 18-20, 1090 Vienna, Austria.

View Article

Download full-text PDF

Source
http://link.springer.com/content/pdf/10.1007/s10354-003-0030
Web Search
http://dx.doi.org/10.1007/s10354-003-0030-3DOI Listing
March 2004

Symptomatic pulmonary embolism and the risk of recurrent venous thromboembolism.

Arch Intern Med 2004 Jan;164(1):92-6

Division of Hematology and Hemostasis, Department of Internal Medicine I, University of Vienna, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/archinte.164.1.92DOI Listing
January 2004

Circulating hematopoietic progenitor cells predict survival in patients with myelofibrosis with myeloid metaplasia.

Haematologica 2003 Nov;88(11):1204-12

Department of Internal Medicine I, Division of Hematology, University of Vienna, Vienna, Austria.

View Article

Download full-text PDF

Source
November 2003

Both chromosome 13 abnormalities by metaphase cytogenetics and deletion of 13q by interphase FISH only are prognostically relevant in multiple myeloma.

Eur J Haematol 2003 Sep;71(3):179-83

Department of Medicine I, Clinical Division of Oncology and Division of Hematology, University Hospital Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1034/j.1600-0609.2003.00111.xDOI Listing
September 2003

High prevalence of elevated clotting factor VIII in chronic thromboembolic pulmonary hypertension.

Thromb Haemost 2003 Sep;90(3):372-6

Department of Internal Medicine II, Division of Cardiology, University of Vienna, Währinger Gürtel 18-20, 1090 Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1160/TH03-02-0067DOI Listing
September 2003

D-dimer levels and risk of recurrent venous thromboembolism.

JAMA 2003 Aug;290(8):1071-4

Department of Internal Medicine I, University of Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jama.290.8.1071DOI Listing
August 2003

The effect of beta-receptor blockade on factor VIII levels and thrombin generation in patients with venous thromboembolism.

Thromb Haemost 2003 May;89(5):837-41

Department of Internal Medicine I, Division of Haematology and Haemostasis, Viena University Hospital, Vienna, Austria.

View Article

Download full-text PDF

Source
May 2003

Superficial thrombophlebitis and risk for recurrent venous thromboembolism.

J Vasc Surg 2003 Apr;37(4):834-8

Department of Internal Medicine I, Division of Hematology and Hemostasis, Vienna University Hospital, Vienna, Austria.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S074152140275298
Publisher Site
http://dx.doi.org/10.1067/mva.2003.157DOI Listing
April 2003

The risk of recurrent venous thromboembolism in heterozygous carriers of factor V Leiden and a first spontaneous venous thromboembolism.

Arch Intern Med 2002 Nov;162(20):2357-60

Department of Internal Medicine I, Division of Hematology and Hemostasis, University of Vienna, Waehringer Guertel 18-20, 1090 Wien, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/archinte.162.20.2357DOI Listing
November 2002